Radiopharmaceutical Diagnosis and Therapy of Sympatho-medullary Disorders

Overview

Journal Ann Nucl Med

Date 1996 Feb 1

PMID 8814734

Authors

B Shapiro

Affiliations

Soon will be listed here.

References

Mozley P, Kim C, Mohsin J, Jatlow A, Gosfield 3rd E, Alavi A . The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. J Nucl Med. 1994; 35(7):1138-44. View

Krenning E, Kwekkeboom D, Bakker W, Breeman W, Kooij P, Oei H . Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993; 20(8):716-31. DOI: 10.1007/BF00181765. View

Nakajo M, Shapiro B, Sisson J, Swanson D, BEIERWALTES W . Salivary gland accumulation of meta-[131I]iodobenzylguanidine. J Nucl Med. 1984; 25(1):2-6. View

Krenning E, Bakker W, Kooij P, Breeman W, Oei H, de Jong M . Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med. 1992; 33(5):652-8. View

Hoefnagel C . Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med. 1994; 21(6):561-81. DOI: 10.1007/BF00173045. View

. The role of [131I]Metaiodobenzylguanidine in the treatment of neural crest tumors. Proceedings of an international workshop. Rome, Italy, September 6-7, 1991. J Nucl Biol Med (1991). 1991; 35(4):177-363. View

Bravo E . Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev. 1994; 15(3):356-68. DOI: 10.1210/edrv-15-3-356. View

Khafagi F, Shapiro B, Fig L, Mallette S, Sisson J . Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med. 1989; 30(4):481-9. View

Shulkin B, Shapiro B, Tobes M, Shen S, Wieland D, Meyers L . Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine. J Nucl Med. 1986; 27(7):1138-42. View

10.

Nakajo M, Shapiro B, Glowniak J, Sisson J, BEIERWALTES W . Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med. 1983; 24(12):1127-34. View

11.

von Moll L, McEwan A, Shapiro B, Sisson J, Gross M, Lloyd R . Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med. 1987; 28(6):979-88. View

12.

Shapiro B, Gross M . Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG. Med Pediatr Oncol. 1987; 15(4):170-7. DOI: 10.1002/mpo.2950150406. View

13.

Hoefnagel C, de Kraker J, VOUTE P, Valdes Olmos R . Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo"). J Nucl Biol Med (1991). 1991; 35(4):248-51. View

14.

Sisson J, Frager M, Valk T, Gross M, Swanson D, Wieland D . Scintigraphic localization of pheochromocytoma. N Engl J Med. 1981; 305(1):12-7. DOI: 10.1056/NEJM198107023050103. View

15.

Wafelman A, Hoefnagel C, Maes R, Beijnen J . Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med. 1994; 21(6):545-59. DOI: 10.1007/BF00173043. View

16.

Fischer M, Kamanabroo D, Sonderkamp H, Proske T . Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine. Lancet. 1984; 2(8395):165. DOI: 10.1016/s0140-6736(84)91081-x. View

17.

Sisson J, Lynch J, Johnson J, Jaques Jr S, Wu D, Bolgos G . Scintigraphic detection of regional disruption of adrenergic neurons in the heart. Am Heart J. 1988; 116(1 Pt 1):67-76. DOI: 10.1016/0002-8703(88)90251-7. View

18.

Wieland D, Swanson D, Brown L, BEIERWALTES W . Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent. J Nucl Med. 1979; 20(2):155-8. View

19.

Hoefnagel C, Taal B, Valdes Olmos R . Role of [131I]metaiodobenzylguanidine therapy in carcinoids. J Nucl Biol Med (1991). 1991; 35(4):346-8. View

20.

Gelfand M . Meta-iodobenzylguanidine in children. Semin Nucl Med. 1993; 23(3):231-42. DOI: 10.1016/s0001-2998(05)80104-7. View